To identify differentially methylated CpGs at the promoter regions of SLIT genes, we analyzed methylation statuses of SLIT1, SLIT2 and SLIT3 genes in tumor and matched normal tissues from 42 NSCLC patients previously reported [25]. This evidence concerns the gene SLIT2 and non-small cell lung carcinoma.